Literature DB >> 34250393

Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.

Andrew Samoyedny1,2, Abhay Srinivasan1,3, Lisa States1,3, Yael P Mosse1,3, Emma Alai1, Bruce Pawel1,3, Jennifer Pogoriler1,3, Sphoorti Shellikeri1, Seth Vatsky1,3, Michael Acord1,3, Fernando Escobar1,3, J Christopher Edgar1, John M Maris1,3, Anne Marie Cahill1,3.   

Abstract

PURPOSE: Many novel therapies for relapsed and refractory neuroblastoma require tumor tissue for genomic sequencing. We analyze our experience with image-guided biopsy in these patients, focusing on safety, yield, adequacy for next-generation sequencing (NGS), and correlation of tumor cell percent (TC%) with quantitative uptake on 123I-meta-iodobenzylguanidine (MIBG) single-photon emission computed tomography with computed tomography (SPECT/CT).
MATERIALS AND METHODS: An 11-year retrospective review of image-guided biopsy on 66 patients (30 female), with a median age of 8.7 years (range, 0.9-49 years), who underwent 95 biopsies (55 bone and 40 soft tissue) of relapsed or refractory neuroblastoma lesions was performed.
RESULTS: There were seven minor complications (7%) and one major complication (1%). Neuroblastoma was detected in 88% of MIBG- or fluorodeoxyglucose-avid foci. The overall NGS adequacy was 69% (64% in bone and 74% in soft tissue, P = .37). NGS adequacy within neuroblastoma-positive biopsies was 88% (82% bone and 96% soft tissue, P = .11). NGS-adequate biopsies had a greater mean TC% than inadequates (51% v 18%, P = .03). NGS-adequate biopsies had a higher mean number of needle passes (7.5 v 3.4, P = .0002). The mean tissue volume from NGS-adequate soft-tissue lesions was 0.16 cm3 ± 0.12. Lesion:liver and lesion:psoas MIBG uptake ratios correlated with TC% (r = 0.74, r = 0.72, and n = 14). Mean TC% in NGS-adequate samples was 51%, corresponding to a lesion:liver ratio of 2.9 and a lesion:psoas ratio of 9.0. Thirty percent of biopsies showed an actionable ALK mutation or other therapeutically relevant variant.
CONCLUSION: Image-guided biopsy for relapsed or refractory neuroblastoma was safe and likely to provide NGS data to guide therapy decisions. A lesion:liver MIBG uptake ratio of ≥ 3 or a lesion:psoas ratio of > 9 was associated with a TC% sufficient to deliver NGS results.
© 2021 by American Society of Clinical Oncology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34250393      PMCID: PMC8232295          DOI: 10.1200/PO.20.00171

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN: 2473-4284


  25 in total

Review 1.  Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.

Authors:  Saif F Hassan; Shawn Mathur; Thomas J Magliaro; Emily L Larimer; Lauren B Ferrell; Sanjeev A Vasudevan; Danielle M Patterson; Chrystal U Louis; Heidi V Russell; Jed G Nuchtern; Eugene S Kim
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

Review 2.  Neuroblastoma: paradigm for precision medicine.

Authors:  Meredith S Irwin; Julie R Park
Journal:  Pediatr Clin North Am       Date:  2015-02       Impact factor: 3.278

Review 3.  Neuroblastoma.

Authors:  Katherine K Matthay; John M Maris; Gudrun Schleiermacher; Akira Nakagawara; Crystal L Mackall; Lisa Diller; William A Weiss
Journal:  Nat Rev Dis Primers       Date:  2016-11-10       Impact factor: 52.329

4.  Diagnostic ultrasound-guided cutting needle biopsies in neuroblastoma: A safe and efficient procedure.

Authors:  Kleopatra Georgantzi; Erik Sköldenberg; Eva Tiensuu Janson; Åke Jakobson; Rolf Christofferson
Journal:  J Pediatr Surg       Date:  2019-01-04       Impact factor: 2.545

5.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

6.  Divergent clonal selection dominates medulloblastoma at recurrence.

Authors:  A Sorana Morrissy; Livia Garzia; David J H Shih; Scott Zuyderduyn; Xi Huang; Patryk Skowron; Marc Remke; Florence M G Cavalli; Vijay Ramaswamy; Patricia E Lindsay; Salomeh Jelveh; Laura K Donovan; Xin Wang; Betty Luu; Kory Zayne; Yisu Li; Chelsea Mayoh; Nina Thiessen; Eloi Mercier; Karen L Mungall; Yusanne Ma; Kane Tse; Thomas Zeng; Karey Shumansky; Andrew J L Roth; Sohrab Shah; Hamza Farooq; Noriyuki Kijima; Borja L Holgado; John J Y Lee; Stuart Matan-Lithwick; Jessica Liu; Stephen C Mack; Alex Manno; K A Michealraj; Carolina Nor; John Peacock; Lei Qin; Juri Reimand; Adi Rolider; Yuan Y Thompson; Xiaochong Wu; Trevor Pugh; Adrian Ally; Mikhail Bilenky; Yaron S N Butterfield; Rebecca Carlsen; Young Cheng; Eric Chuah; Richard D Corbett; Noreen Dhalla; An He; Darlene Lee; Haiyan I Li; William Long; Michael Mayo; Patrick Plettner; Jenny Q Qian; Jacqueline E Schein; Angela Tam; Tina Wong; Inanc Birol; Yongjun Zhao; Claudia C Faria; José Pimentel; Sofia Nunes; Tarek Shalaby; Michael Grotzer; Ian F Pollack; Ronald L Hamilton; Xiao-Nan Li; Anne E Bendel; Daniel W Fults; Andrew W Walter; Toshihiro Kumabe; Teiji Tominaga; V Peter Collins; Yoon-Jae Cho; Caitlin Hoffman; David Lyden; Jeffrey H Wisoff; James H Garvin; Duncan S Stearns; Luca Massimi; Ulrich Schüller; Jaroslav Sterba; Karel Zitterbart; Stephanie Puget; Olivier Ayrault; Sandra E Dunn; Daniela P C Tirapelli; Carlos G Carlotti; Helen Wheeler; Andrew R Hallahan; Wendy Ingram; Tobey J MacDonald; Jeffrey J Olson; Erwin G Van Meir; Ji-Yeoun Lee; Kyu-Chang Wang; Seung-Ki Kim; Byung-Kyu Cho; Torsten Pietsch; Gudrun Fleischhack; Stephan Tippelt; Young Shin Ra; Simon Bailey; Janet C Lindsey; Steven C Clifford; Charles G Eberhart; Michael K Cooper; Roger J Packer; Maura Massimino; Maria Luisa Garre; Ute Bartels; Uri Tabori; Cynthia E Hawkins; Peter Dirks; Eric Bouffet; James T Rutka; Robert J Wechsler-Reya; William A Weiss; Lara S Collier; Adam J Dupuy; Andrey Korshunov; David T W Jones; Marcel Kool; Paul A Northcott; Stefan M Pfister; David A Largaespada; Andrew J Mungall; Richard A Moore; Nada Jabado; Gary D Bader; Steven J M Jones; David Malkin; Marco A Marra; Michael D Taylor
Journal:  Nature       Date:  2016-01-13       Impact factor: 49.962

7.  Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.

Authors:  Olivia M Padovan-Merhar; Pichai Raman; Irina Ostrovnaya; Karthik Kalletla; Kaitlyn R Rubnitz; Eric M Sanford; Siraj M Ali; Vincent A Miller; Yael P Mossé; Meaghan P Granger; Brian Weiss; John M Maris; Shakeel Modak
Journal:  PLoS Genet       Date:  2016-12-20       Impact factor: 5.917

8.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

9.  Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

Authors:  Xiaotu Ma; Yu Liu; Yanling Liu; Ludmil B Alexandrov; Michael N Edmonson; Charles Gawad; Xin Zhou; Yongjin Li; Michael C Rusch; John Easton; Robert Huether; Veronica Gonzalez-Pena; Mark R Wilkinson; Leandro C Hermida; Sean Davis; Edgar Sioson; Stanley Pounds; Xueyuan Cao; Rhonda E Ries; Zhaoming Wang; Xiang Chen; Li Dong; Sharon J Diskin; Malcolm A Smith; Jaime M Guidry Auvil; Paul S Meltzer; Ching C Lau; Elizabeth J Perlman; John M Maris; Soheil Meshinchi; Stephen P Hunger; Daniela S Gerhard; Jinghui Zhang
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

10.  Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma.

Authors:  Samuel L Brady; Barry L Shulkin
Journal:  EJNMMI Phys       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.